{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:16:12Z","timestamp":1790018172770,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/26\/D\/NZ3\/01119"],"award-info":[{"award-number":["2017\/26\/D\/NZ3\/01119"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","award":["SUB\/1\/DN\/20\/005\/1118"],"award-info":[{"award-number":["SUB\/1\/DN\/20\/005\/1118"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.112057","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T01:51:00Z","timestamp":1629337860000},"page":"112057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Cannabidiol \u2013 A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance"],"prefix":"10.1016","volume":"142","author":[{"given":"Tomasz","family":"Charytoniuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Sztolsztener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Harasim-Symbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Konstantynowicz-Nowicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112057_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2013.95","article-title":"The western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence","author":"Oddy","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.112057_bib2","article-title":"Effect of diet on type 2 diabetes mellitus: a review","author":"Sami","year":"2017","journal-title":"Int. J. Health Sci."},{"key":"10.1016\/j.biopha.2021.112057_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.112057_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2013.12.004","article-title":"How does brain insulin resistance develop in Alzheimer\u2019s disease?","author":"De Felice","year":"2014","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.biopha.2021.112057_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer\u2019s disease a Type 3 Diabetes? A critical appraisal","author":"Kandimalla","year":"2017","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2021.112057_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/105828","article-title":"Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer\u2019s disease","author":"Verdile","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2021.112057_bib7","doi-asserted-by":"crossref","DOI":"10.2337\/db08-0586","article-title":"Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2021.112057_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","author":"Talbot","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2021.112057_bib9","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","article-title":"Bioactive sphingolipids: metabolism and function","volume":"50","author":"Bartke","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.112057_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2021.112057_bib11","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1016\/j.febslet.2006.02.067","article-title":"Tau phosphorylation and aggregation in Alzheimer\u2019s disease pathology","volume":"580","author":"Avila","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2021.112057_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00249","article-title":"Sphingolipid metabolism: a new therapeutic opportunity for brain degenerative disorders","author":"Di Pardo","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2021.112057_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143564","article-title":"Alteration of sphingolipids in biofluids: implications for neurodegenerative diseases","author":"Pujol-Lereis","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112057_bib14","first-page":"153","article-title":"Endocannabinoid system: an overview of its potential in current medical practice","volume":"30","author":"Mouslech","year":"2009","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.biopha.2021.112057_bib15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jnc.14098","article-title":"Endocannabinoid system in neurodegenerative disorders","volume":"142","author":"Basavarajappa","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2021.112057_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/nu11081956","article-title":"Lifestyle and metabolic syndrome: contribution of the endocannabinoidome","author":"Di Marzo","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2021.112057_bib17","article-title":"The endocannabinoid system in obesity and type 2 diabetes","author":"Marzo","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2021.112057_bib18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/ijms21041423","article-title":"Targeting peripherally restricted cannabinoid receptor 1, cannabinoid receptor 2, and endocannabinoid-degrading enzymes for the treatment of neuropathic pain including neuropathic orofacial pain","volume":"21","author":"Hossain","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112057_bib19","article-title":"The endocannabinoid system in the adipose organ","author":"Jung","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.biopha.2021.112057_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-019-1248-9","article-title":"The expanded endocannabinoid system\/endocannabinoidome as a potential target for treating diabetes mellitus","volume":"19","author":"Veilleux","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.biopha.2021.112057_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13226","article-title":"Role of the endocannabinoid system in diabetes and diabetic complications","author":"Gruden","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112057_bib22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajpath.2011.11.003","article-title":"The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications","volume":"180","author":"Horv\u00e1th","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2021.112057_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/can.2015.0004","article-title":"Identification of psychoactive degradants of cannabidiol in simulated gastric and physiological fluid","volume":"1","author":"Merrick","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.biopha.2021.112057_bib24","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"Rajesh","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2021.112057_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1748-1716.2007.01755.x","article-title":"Effect of exercise duration on ceramide metabolism in the rat heart","volume":"192","author":"Baranowski","year":"2008","journal-title":"Acta Physiol."},{"key":"10.1016\/j.biopha.2021.112057_bib26","first-page":"497","article-title":"A simple method for the isolation and purfication of total lipides from animal tissues","volume":"55","author":"Folch","year":"1956","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.112057_bib27","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apha.12022","article-title":"Fatty acid transporters involved in the palmitate and oleate induced insulin resistance in primary rat hepatocytes","volume":"207","author":"Chabowski","year":"2013","journal-title":"Acta Physiol."},{"key":"10.1016\/j.biopha.2021.112057_bib28","doi-asserted-by":"crossref","DOI":"10.2174\/1871527316666170413114210","article-title":"Neurological aspects of medical use of cannabidiol","author":"Mannucci","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.biopha.2021.112057_bib29","doi-asserted-by":"crossref","DOI":"10.4103\/1319-3767.114505","article-title":"The role of endocannabinoids system in fatty liver disease and therapeutic potentials","author":"Alswat","year":"2013","journal-title":"Saudi J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.112057_bib30","doi-asserted-by":"crossref","DOI":"10.2337\/dc16-0650","article-title":"Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel group pilot study","author":"Jadoon","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2021.112057_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2009.04.001","article-title":"Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression","author":"Rieder","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.biopha.2021.112057_bib32","doi-asserted-by":"crossref","DOI":"10.3747\/co.23.3080","article-title":"Anticancer mechanisms of cannabinoids","author":"Velasco","year":"2016","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.biopha.2021.112057_bib33","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1074\/jbc.275.12.9078","article-title":"Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis","volume":"275","author":"Perry","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.112057_bib34","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-08-0361","article-title":"Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism","author":"Gustafsson","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2021.112057_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/0006-291X(84)90702-2","article-title":"Stimulation of sphingomyelin hydrolysis by cannabidiol in fibroblasts from a Niemann-Pick patient","author":"Burstein","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2021.112057_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/S1566-3124(03)12006-8","article-title":"Sphingomyelin and ceramide in brain aging, neuronal plasticity and neurodegenerative disorders","author":"Mattson","year":"2003","journal-title":"Adv. Cell Aging Gerontol."},{"key":"10.1016\/j.biopha.2021.112057_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2008.05.010","article-title":"Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease","author":"He","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2021.112057_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2018.09.012","article-title":"Inhibition of sphingomyelin synthase 1 ameliorates alzheimer-like pathology in APP\/PS1 transgenic mice through promoting lysosomal degradation of BACE1","author":"Lu","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2021.112057_bib39","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-2011-111202","article-title":"Increased ceramide in brains with alzheimer\u2019s and other neurodegenerative diseases","author":"Filippov","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.biopha.2021.112057_bib40","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1429-16.2016","article-title":"Neutral sphingomyelinase-2 deficiency ameliorates Alzheimer\u2019s disease pathology and improves cognition in the 5XFAD mouse","author":"Dinkins","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2021.112057_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2014.10.002","article-title":"Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes","author":"Shamseddine","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.biopha.2021.112057_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-019-0965-z","article-title":"Role of cholesterol and sphingolipids in brain development and neurological diseases","author":"Hussain","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2021.112057_bib43","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1074\/jbc.M212307200","article-title":"A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids","volume":"278","author":"Chavez","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.112057_bib44","doi-asserted-by":"crossref","DOI":"10.1517\/14728222.12.10.1265","article-title":"Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes","author":"MacAulay","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2021.112057_bib45","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2337\/db15-1428","article-title":"Brain insulin signaling is increased in insulin-resistant states and decreases in FOXOs and PGC-1\u03b1 and increases in A\u03b21-40\/42 and phospho-Tau May Abet Alzheimer development","volume":"65","author":"Sajan","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2021.112057_bib46","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1242\/jcs.01558","article-title":"Tau phosphorylation in neuronal cell function and dysfunction","volume":"117","author":"Johnson","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2021.112057_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrendo.2016.169","article-title":"Sphingolipids and phospholipids in insulin resistance and related metabolic disorders","volume":"13","author":"Meikle","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2021.112057_bib48","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/er.2007-0025","article-title":"Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism","volume":"29","author":"Holland","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.biopha.2021.112057_bib49","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides \u2013 lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2021.112057_bib50","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ijo.2012.191","article-title":"Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet","volume":"37","author":"Brozinick","year":"2013","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2021.112057_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2013.01.041","article-title":"Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction","author":"Dekker","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2021.112057_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2013.06.002","article-title":"Analysis of the \u201cendocannabinoidome\u201d in peripheral tissues of obese Zucker rats","author":"Iannotti","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.biopha.2021.112057_bib53","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.bjp.0707399","article-title":"Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences","volume":"152","author":"McPartland","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112057_bib54","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112057_bib55","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112057_bib56","doi-asserted-by":"crossref","DOI":"10.1530\/EC-18-0535","article-title":"Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesity","author":"Simcocks","year":"2019","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.biopha.2021.112057_bib57","article-title":"Advances in the physiology of GPR55 in the central nervous system","author":"Marichal-Cancino","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2021.112057_bib58","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201800171R","article-title":"GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues","author":"Lipina","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2021.112057_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.595635","article-title":"Cannabidiol as a therapeutic target: evidence of its neuroprotective and neuromodulatory function in Parkinson\u2019s disease","volume":"11","author":"Patricio","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"2008","key":"10.1016\/j.biopha.2021.112057_bib60","article-title":"Peroxisome proliferator-activated receptors: \u201ckey\u201d regulators of neuroinflammation after traumatic brain injury","author":"Stahel","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.biopha.2021.112057_bib61","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2021.112057_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2019.01.008","article-title":"Protective effects of 5-HT 1A receptor antagonist and 5-HT 2A receptor agonist on the biochemical and histological features in a rat model of Alzheimer\u2019s disease","author":"Afshar","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.biopha.2021.112057_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00162","article-title":"The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory","author":"Stiedl","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112057_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2010.03.019","article-title":"5-HT1A receptor-regulated signal transduction pathways in brain","author":"Polter","year":"2010","journal-title":"Cell. Signal."},{"issue":"2011","key":"10.1016\/j.biopha.2021.112057_bib65","article-title":"GSK3 function in the brain during development, neuronal plasticity, and neurodegeneration","author":"Salcedo-Tello","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"issue":"6938","key":"10.1016\/j.biopha.2021.112057_bib66","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3\u03b1 regulates production of Alzheimer\u2019s disease amyloid-\u03b2 peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:38:26Z","timestamp":1760099906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221008404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":66,"alternative-id":["S0753332221008404"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112057","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol \u2013 A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112057"}}